Medicure Inc. (CVE:MPH – Get Free Report)’s stock price crossed below its 200-day moving average during trading on Friday . The stock has a 200-day moving average of C$0.87 and traded as low as C$0.68. Medicure shares last traded at C$0.68, with a volume of 4,500 shares.
Medicure Stock Down 13.9 %
The firm has a market cap of C$7.10 million, a price-to-earnings ratio of -3.49 and a beta of 0.90. The business has a fifty day simple moving average of C$0.79 and a 200 day simple moving average of C$0.87. The company has a debt-to-equity ratio of 4.65, a current ratio of 2.03 and a quick ratio of 1.29.
About Medicure
Medicure Inc, a biopharmaceutical company, engages in the research, development, and commercialization of human therapies in the United States. The company markets and distributes AGGRASTAT injection, a glycoprotein GP IIb/IIIa receptor antagonist for the treatment of acute coronary syndrome, including unstable angina and non-Q-wave myocardial infarction.
Further Reading
- Five stocks we like better than Medicure
- Differences Between Momentum Investing and Long Term Investing
- Newsmax’s IPO Whiplash: Meme Stock Hype or Growth Potential?
- Mastering Discipline: Overcoming Emotional Challenges In Trading
- Disney 2025 Shareholders: Major Updates for Investors
- 2 Fintech Stocks to Buy Now and 1 to Avoid
- Advance Auto Parts Stock: A Classic Rebound Play in the Making
Receive News & Ratings for Medicure Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Medicure and related companies with MarketBeat.com's FREE daily email newsletter.
